The penny stock of MusclePharm Corp. (OTC: MSLP) opened up a “can of whoop ass” to end the week as shares surged to $0.239 leading all the OTC stocks in volume. MSLP, one of our recent stock picks, traded as high as $0.244 towards the end of the trading session before ending the day up 40.59% on volume of 51.79 million.
Free Stock Trading Tip: Add MSLP to your list of penny stocks to watch.
MusclePhram, a worldwide nutritional supplement provider, announced to shareholders on Friday that they are finalizing agreements with two top U.S. retail chain stores which collectively have over 9,000 stores in the U.S. to supply MSLP supplements and the company’s MMA Elite branded product. On top of that, Strategic Apex Group, LLC, an executive and board compensation consulting firm, got the top MSLP executives to agree to a new compensation package effective May 1, 2012, which bases pay and bonuses on performance.
Looking for Hot Penny Stocks? Join Our Newsletter and get our next Penny Stock Picks FREE
Hot Penny Stocks w/ Highest Volume
|MSLP||Muscle Pharm Corp.||0.0239||40.59%||0.0244||51.79 m|
|CYNX||CelLynx Group||0.001||-9.09%||0.0012||43.05 m|
|NEOM||NeoMedia Technologies||0.0148||-12.43%||0.0187||42.56 m|
|SNPK||Sunpeaks Ventures||1.19||5.31%||1.33||33.81 m|
|NXOI||Next 1 Interactive||0.0008||14.29%||0.0008||32.47 m|
|GNTA||Genta Inc.||0.0013||-7.14%||0.0015||26.46 m|
|LQMT||Liquidmetal Technologies||0.41||41.33%||0.48||24.71 m|
|ECDC||East Coast Diversified Corp.||0.0035||-7.89%||0.004||20.21 m|
|MDCE||Medical Care Technologies||0.0009||12.50%||0.0009||18.36 m|
|XDSL||mPhase Technologies||0.0011||10.00%||0.0012||18.33 m|
MSLP Stock Snap Shot:
Per 10-K: 605.93M
52 Week High
52 Week Low
5 Day Look Back
Pct Change -5.53%
Moving Avg 0.0196
Avg Volume 35.11M
10 Day Look Back
Pct Change -16.14%
Moving Avg 0.0227
Avg Volume 21.99M
Last Volume 1,000,000
Up Volume 7,825,578
Neutral Volume 19,646,705
Down Volume 24,319,439
Avg Trade Size 92,320
With a business plan, capital plan and corporate plan in place for 2012 that reflect MusclePharm’s current stage of growth and development, coupled with the recently retirement of all of MSLP‘s convertible notes, the sky is the limit for this growing company.
To view the SEC filings and recent 10-K for MSLP, click here.
Bottom Line: With revenues for 2011 coming in at $20,838,337 compared to $4,047,295 for 2010 raising gross profit to $6,367,723, it seems that MusclePharm is headed in the right direction. With the expansion of its product sales, MSLP should bee added to your list of hot penny stocks to buy radar.
Can MSLP get back to $1.18? Under the current share structure it would be a huge feat but it is very possible you could see MSLP break its 52 week high before summer’s end.